Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia

International Journal of Cancer

Volumn 129, Issue 4, 2011, Pages 965-973

  Chang, Ya Ju ^a   Chen, Hui Chi ^a,b   Lee, Bor Heng ^c   You, San Lin ^a,b   Lin, Ching Yu ^d   Pan, Mei Hung ^b   Chou, Yi Chun ^a   Hsieh, Chang Yao ^e   Chen, Yi Ming A ^f   Cheng, Yu Juen ^a   Chen, Chien Jen ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c King Car Food Industrial Co Ltd   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

cervical neoplasia; HPV 52; HPV 58; variants

Indexed keywords

VIRUS DNA;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANALYTICAL EQUIPMENT; ARTICLE; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; E6 GENE; E7 GENE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; MAJOR CLINICAL STUDY; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; TAIWAN; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS GENE;

ADULT; AGED; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; TAIWAN; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 79959716884     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25724     Document Type: Article

References (31)

1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V,. A review of human carcinogens. Part B. Biological agents. Lancet Oncol 2009; 10: 321-2.
2. Munoz N, Bosch FX, Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders JF, Meijer JLM,. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27. (Pubitemid 36159887)
3. Huang S, Afonina I, Miller BA, Beckmann AM,. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 1997; 70: 408-11. (Pubitemid 27107267)
4. Lin QQ, Yu SZ, Qu W, Cruz Y, Burk RD,. Human papillomavirus types 52 and 58. Int J Cancer 1998; 75: 484-5.
5. Liaw KL, Hsing AW, Chen CJ, Schiffman MH, Zhang TY, Hsieh CY, Greer CE, You SL, Huang TW, Wu TC, Oleary TJ, Seidman JD, et al. Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer 1995; 62: 565-71.
6. Huang YK, You SL, Yuan CC, Ke YM, Cao JM, Liao CY, Wu CH, Hsu CS, Huang KF, Lu CH, Twu NF, Chu TY,. Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening. Br J Cancer 2008; 98: 863-9.
7. Lin H, Ma YY, Moh JS, Ou YC, Shen SY, ChangChien CC,. High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 2006; 101: 40-5.
8. Lai CH, Huang HJ, Hsueh S, Chao A, Lin CT, Huang SL, Chao FY, Qiu JT, Hong JH, Chou HH, Chang TC, Chang CJ,. Human papillomavirus genotype in cervical cancer: a population-based study. Int J Cancer 2007; 120: 1999-2006. (Pubitemid 46418380)
9. Chen HC, You SL, Hsieh CY, Schiffman M, Lin CY, Pan MH, Chou YC, Liaw KL, Hsing AW, Chen CJ,. Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: a community-based survey of 10602 women. Int J Cancer, DOI. 10.1002/ijc.25685.
10. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H,. Classification of papillomaviruses. Virology 2004; 324: 17-27. (Pubitemid 38737395)
11. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Kahn T, Kiviat N, Lancaster W, Mavromara-Nazos P, Labropoulou V, Mitrani-Rosenbaum S, et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 1993; 67: 6413-23. (Pubitemid 23309105)
12. Chen Z, Terai M, Fu L, Herrero R, DeSalle R, Burk RD,. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 2005; 79: 7014-23. (Pubitemid 40677333)
13. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 2010; 70: 3159-69.
14. Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, Pfister H, Tay SK, Meulen JT, Villa LL, Bernard HU,. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 1993; 67: 6424-31. (Pubitemid 23309106)
15. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM,. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997; 71: 2463-72. (Pubitemid 27078630)
16. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL,. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 2007; 120: 1763-8. (Pubitemid 46399363)
17. Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB,. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev 2007; 16: 4-10. (Pubitemid 46174256)
18. Aho JP, Hankins C, Tremblay C, Lang F, Forest P, Pourreaux K, Rouah F, Coutlee F,. Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women. J Infec Dis 2003; 188: 1517-27. (Pubitemid 37523937)
19. Calleja-Macias IE, Villa LL, Prado JC, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Chu TY, Cubie HA, et al. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol 2005; 79: 13630-40. (Pubitemid 41508175)
20. Chan PK, Lam CW, Cheung TH, Li WW, Lo KW, Chan MY, Cheung JL, Cheng AF,. Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst 2002; 94: 1249-53. (Pubitemid 34993876)
21. Raiol T, Wyant PS, De Amorim RMS, Cerqueira DM, Milanezi NV, Brigido MD, Sichero L, Martins CRF,. Genetic variability and phylogeny of the high-risk HPV-31,-33,-35,-52, and-58 in Central Brazil. J Med Virol 2009; 81: 685-92.
22. Wu EQ, Zha X, Yu XH, Zhang GN, Wu YG, Fan Y, Ren Y, Kong LQ, Kong W,. Profile of physical status and gene variation of human papillomavirus 58 genome in cervical cancer. J Gen Virol 2009; 90: 1229-37.
23. Xin CY, Matsumoto K, Yoshikawa H, Yasugi T, Onda T, Nakagawa S, Yamada M, Nozawa S, Sekiya S, Hirai Y, Shiromizu K, Fujii T, et al. Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett 2001; 170: 19-24. (Pubitemid 32607656)
24. Aho JP, Hankins C, Tremblay C, Forest P, Pourreaux K, Rouah F, Coutlee F,. Genomic polymorphism of human papillomaviru type 52 predisposes toward persistent infection in sexually active women. J Infec Dis 2004; 190: 46-52. (Pubitemid 38858403)
25. Giannoudis A, Herrington CS,. Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 2001; 193: 295-302. (Pubitemid 32229859)
26. Lin CY, Chen HC, Lin RW, You SL, You CM, Chuang LC, Pan MH, Lee MH, Choub YC, Chen CJ,. Quality assurance of genotyping array for detection and typing of human papillomavirus. J Virol Methods 2007; 140: 1-9.
27. Delius H, Hoffmann B,. Primer-directed sequencing of human papillomavirus types. Curr Top Microbiol Immunol 1994; 186: 13-31. (Pubitemid 24099083)
28. Kirii Y, Iwamoto S, Matsukura T,. Human papillomavirus type 58 DNA sequence. Virology 1991; 185: 424-7.
29. Lai HC, Sun CA, Yu MH, Chen HJ, Liu HS, Chu TY,. Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types. Int J Cancer 1999; 84: 553-7.
30. Zuna RE, Moore WE, Shanesmith RP, Dunn ST, Wang SS, Schiffman M, Blakey GL, Teel T,. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer 2009; 125: 2609-13.
31. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Marongiu A, Gissmann L, Wilander E, Tommasino M,. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 2001; 94: 711-6. (Pubitemid 33035692)